Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Will 2013 see more medtech migration into pharma arena?

This article was originally published in Clinica

Executive Summary

Looking ahead at what's in store for 2013, one of the overarching trends that Clinica predicts is the increased presence of medtech players in areas that have until now been traditionally dominated by pharma. This itself could lead to more cross-sector investment/partnerships with pharma firms potentially looking to maintain their stronghold in a disease area and buy medtech alternatives to their drug offering, or medtech firms partnering with pharma to develop the devices required for more effective delivery of drugs.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT099807

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel